Willamette Valley Cancer Institute is a clinical research site located in Springfield, Oregon, United States 97477.
Crixeo Clinical Trials Trust Score: 12/100 (FAILING). This profile has not yet been claimed by the site owner.
Willamette Valley Cancer Institute has participated in 4 clinical trials.
Therapeutic areas: Platinum Resistant Ovarian Cancer, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma.
Sponsors: Mateon Therapeutics, Revolution Medicines, Inc., Celgene.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Oregon · View every site in Springfield
Trust Score: 12/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Willamette Valley Cancer Institute has a Crixeo Trust Score of 12/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Willamette Valley Cancer Institute has 4 clinical trials on record. Their work covers Platinum Resistant Ovarian Cancer, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma.
Willamette Valley Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.